NESS - Improving Left Ventricular Function And Angiogenesis After MI In Flk Knock Out Mice With Intramyocardial Gene Therapy With Pellino1, a Novel Molecule In VEGF Signaling Pathway

Back to 2015 Annual Meeting Posters

Improving Left Ventricular Function And Angiogenesis After MI In Flk Knock Out Mice With Intramyocardial Gene Therapy With Pellino1, a Novel Molecule In VEGF Signaling Pathway
*Ibnalwalid Saad¹^,2, *Mahesh Thirunavukkarasu², *Vladimir Coca-Soliz¹, *Vathinathen Selvaraju², J. Alexander Palesty¹, *Nilanjana Maulik²
¹Saint Mary's Hospital, Waterbury, CT;²University of Connecticut Health, Farmington, CT

Objective:
In the present study we attempted to see whether Peli1 gene therapy can rescue disruption of cardioprotection and angiogenesis in Flk-1+/- mice subjected to MI
Design:
A preclincal animal study, duration of follow up is 30 days
Setting:
Molecular Cardiology and Angiogenesis Laboratory; University Research Facility
Patients:
Flk-1+/- mice in two groups: 1-Ad.Peli1MI and 2-Ad.LacZMI.
Interventions:
Flk+/- mice underwent MI by ligation of left anterior descending coronary artery(LAD). Following LAD ligation surgery mice were treated by either intramyocardial adenopellino1(Ad.Peli1MI) or adenoLacz(Ad.LacZMI).
Main Outcome Measures:
Echocardiographic analysis was performed preoperatively and on postoperative day 30. Heart tissue was collected on postoperative day 30 for immunohistochemistry(IHC) to measure capillary density and fibrosis.
Results:
Echocardiogram revealed increased EF [45% ± 1.46 vs. 24% ± 0.87 (n=9-11); p<0.05] and FS [23% ± 0.86 vs. 11% ± 0.45 (n=9-11); p<0.05)] along with decreased LVIDs [4.2 mm ± 0.16 vs. 5.4 mm ± 0.22 (n=9-11; p<0.05)] in Ad.Peli1MI group as compared to Ad.LacZMI. Vessel density staining showed increased number of capillaries in the Ad.Peli1MI group [2408 ± 60.45 vs. 2011 ± 112.4 (counts/mm2, n=6-7; p<0.05)] as compared to Ad.LacZMI. Also IHC for fibrosis exhibited decreased collagen deposition in Ad.Peli1MI group [7% ± 0.44 vs. 14% ± 0.39 (n=7-11); p<0.05] as compared to Ad.LacZMI.
Conclusions:
Peli1 gene therapy can promote angiogenesis, diminish cardiac fibrosis, and improve myocardial function in Flk1+/- mice subjected to MI. These findings have great clincal potential for future therapy in humans as a powerful tool to assist in injured myocardial tissue recovery following an MI.

Back to 2015 Annual Meeting Posters